• Complix receives €1.2 million VLAIO grant to develop a novel and differentiated class of anti-Covid-19 Alphabody™ therapeutics

    Wednesday October 7th 2020

  • CRISPRing trees for a climate-friendly economy

    Wednesday October 7th 2020

  • Biocartis announces market release of SeptiCyte® RAPID test on Idylla™

    Tuesday October 6th 2020

  • Mithra announces FDA update

    Tuesday October 6th 2020

  • argenx expands capabilities in antibody engineering through key technology partnerships

    Tuesday October 6th 2020

  • Hedwig Maes appointed new CEO of Agidens

    Monday October 5th 2020

  • Bone Therapeutics, Link Health and Pregene to develop and commercialize the ALLOB allogeneic bone cell therapy platform in China and Southeast Asia

    Monday October 5th 2020

  • argenx presents additional Efgartigimod data from Global Phase 3 ADAPT Trial

    Monday October 5th 2020

  • Your news here?

  • Biocartis joins COVID-19 Testing Industry Consortium of nineteen healthcare community organizations

    Thursday October 1st 2020

  • Imec announces whole genome data analysis available in just a few hours

    Thursday October 1st 2020

  • Biotalys awarded €1.1 million VLAIO research grant

    Thursday October 1st 2020


Strategic Partners